{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:30:52Z","timestamp":1762673452710},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1993,6,1]],"date-time":"1993-06-01T00:00:00Z","timestamp":738892800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[1993,6]]},"DOI":"10.1007\/bf01208846","type":"journal-article","created":{"date-parts":[[2005,2,25]],"date-time":"2005-02-25T10:46:13Z","timestamp":1109328373000},"page":"360-362","source":"Crossref","is-referenced-by-count":10,"title":["Diethyldithiocarbamate chemoprotection of carboplatin-induced hematological toxicity"],"prefix":"10.1007","volume":"119","author":[{"given":"Prudence","family":"Francis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurie","family":"Markman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hakes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie","family":"Reichman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"John L.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Curtin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hoskins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01208846_CR1","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.1992.10.5.706","volume":"10","author":"DS Alberts","year":"1989","unstructured":"Alberts DS, Green S, Hannigan EV, O'Toole R, Stock-Novack D, Anderson P, Surwit EA, Malvlya VK, Nahhas WA, Jolles CJ (1989) Improved therapeutic index of carboplatin plus cyclophosphamide vs cisplatin plus cyclophosphamide: final report of a phase III randomized trial in stages III\u2013IV ovarian cancer. J Clin Oncol 10:706\u2013717","journal-title":"J Clin Oncol"},{"key":"BF01208846_CR2","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.1990.8.9.1585","volume":"8","author":"MJ Berry","year":"1990","unstructured":"Berry MJ, Jacobs C, Halsey J, Borch R (1990) Modification of cisplatin toxicity with diethyldithiocarbamate. J Clin Oncol 8:1585\u20131590","journal-title":"J Clin Oncol"},{"key":"BF01208846_CR3","first-page":"2751","volume":"46","author":"DL Bodenner","year":"1986","unstructured":"Bodenner DL, Dedon PC, Keng DC, Katz JC, Borch RF (1986) Selective protection againstcis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate. Cancer Res 46:2751\u20132755","journal-title":"Cancer Res"},{"key":"BF01208846_CR4","doi-asserted-by":"crossref","first-page":"6611","DOI":"10.1073\/pnas.76.12.6611","volume":"76","author":"RF Borch","year":"1979","unstructured":"Borch RF, Pleasant ME (1979) Inhibition of cisplatin nephrotoxicity by diethyldithiocarbamate rescue in a rat model. Proc Natl Acad Sci USA 76:6611\u20136614","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01208846_CR5","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1073\/pnas.77.9.5441","volume":"77","author":"RF Borch","year":"1980","unstructured":"Borch RF, Katz JC, Lieder PH, Pleasants ME (1980) Effects of diethyldithiocarbamate rescue on tumor response to cisplatinum in a rat model. Proc Natl Acad Sci USA 77:5441\u20135444","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF01208846_CR6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0277-5379(87)90284-7","volume":"23","author":"SE Dible","year":"1987","unstructured":"Dible SE, Siddik ZH, Boxall FE, Harrap K (1987) The effect of diethyldithiocarbamate on the hematological toxicity and antitumor activity of carboplatin. Eur J Cancer Clin Oncol 23:813\u2013818","journal-title":"Eur J Cancer Clin Oncol"},{"key":"BF01208846_CR7","first-page":"3686","volume":"44","author":"RG Evans","year":"1984","unstructured":"Evans RG, Wheatley C, Engel C, Nielsen J, Ciborowski LJ (1984) Modification of bone marrow toxicity ofcis-diamminedichloroplatinum(II) in mice by diethyldithiocarbamate. Cancer Res 44:3686\u20133690","journal-title":"Cancer Res"},{"key":"BF01208846_CR8","first-page":"5708","volume":"48","author":"A Gringeri","year":"1988","unstructured":"Gringeri A, Keng PC, Borch RF (1988) Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused bycis-diamminedichloroplatinum(II) or diammine(1,1-cyclobutane dicarboxylato)platinum(II). Cancer Res 48:5708\u20135712","journal-title":"Cancer Res"},{"key":"BF01208846_CR9","first-page":"2","volume":"6","author":"EM Hersh","year":"1987","unstructured":"Hersh EM, Petersen E, Yocum DE, Gorman RS, Darragh JM (1987) Dose response study of diethyldithiocarbamate in patients with ARC and Aids. Proc Am Soc Clin Oncol 6:2","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF01208846_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1200\/JCO.1991.9.3.389","volume":"9","author":"M Markman","year":"1991","unstructured":"Markman M, Rothman R, Hakes T, Reichman B, Hoskins W, Rubin S, Jones W, Almadrones L, Lewis JL Jr (1991) Second-line platinum therapy in patients with ovarian cancer previously treated with cis-platin. J Clin Oncol 9:389\u2013393","journal-title":"J Clin Oncol"},{"key":"BF01208846_CR11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.1988.6.6.955","volume":"6","author":"J Paredes","year":"1988","unstructured":"Paredes J, Hong WK, Felder TB, Dimery IW, Choski AJ, Newan RA, Castellanos AM, Robbins KT, McCarthy K, Atkinson N, Kramer AM, Hersh EV, Goepert H (1988) Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and\/or metastatic squamous cell carcinoma on the head and neck. J Clin Oncol 6:955\u2013964","journal-title":"J Clin Oncol"},{"key":"BF01208846_CR12","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jnci\/80.18.1488","volume":"80","author":"ML Rothenberg","year":"1988","unstructured":"Rothenberg ML, Ostchega Y, Steinberg SM, Young RC, Hummel S, Ozols RF (1988) High-dose carboplatin with diethyldithiocarbamate chemoprotection in treatment of women with relapsed ovarian cancer. JNCI 80:1488\u20131492","journal-title":"JNCI"},{"key":"BF01208846_CR13","first-page":"6629","volume":"49","author":"TK Smalbach","year":"1989","unstructured":"Smalbach TK, Borch RF (1989) Diethyldithiocarbamate modulation of murine bone marrow toxicity induced bycis-diammine-(cyclobutanedicarboxylato)platinum(II). Cancer Res 49:6629\u20136633","journal-title":"Cancer Res"},{"key":"BF01208846_CR14","first-page":"6218","volume":"50","author":"TK Smalbach","year":"1990","unstructured":"Smalbach TK, Borch RF (1990) Mechanism of diethyldithiocarbamate modulation of murine bone marrow toxicity. Cancer Res 50:6218\u20136221","journal-title":"Cancer Res"},{"key":"BF01208846_CR15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1200\/JCO.1992.10.5.718","volume":"10","author":"K Swenerton","year":"1992","unstructured":"Swenerton K, Jeffrey J, Stuart G, Roy M, Krepart G, Carmichael J, Drouin P, Stanimir R, O'Connell G, MacLean G, Kirk ME, Canetta R, Koski B, Shelley W, Zee B, Pater J (1992) Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the national cancer institute of Canada clinical trials group. J Clin Oncol 10:718\u2013726","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01208846.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01208846\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01208846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01208846.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T18:19:39Z","timestamp":1581963579000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01208846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1993,6]]}},"alternative-id":["BF01208846"],"URL":"https:\/\/doi.org\/10.1007\/bf01208846","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,6]]}}}